Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.
Clinical trial NCT06139991 · COMPLETED
Trial details
- NCT number
- NCT06139991
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2024-05-04
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.